Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update

Ta Wei Tai, Chun Feng Huang, Huei Kai Huang, Rong Sen Yang, Jung Fu Chen, Tien Tsai Cheng, Fang Ping Chen, Chung Hwan Chen, Yin Fan Chang, Wei Chieh Hung, Der Sheng Han, Ding Cheng Chan, Ching Chou Tsai, I. Wen Chen, Wing P. Chan, Husan Jui Chang, Jawl Shan Hwang*, Chih Hsing Wu*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

19 Scopus citations

Abstract

Osteoporosis greatly increases the risk of fractures. Osteoporotic fractures negatively impact quality of life, increase the burden of care, and increase mortality. Taiwan is an area with a high prevalence of osteoporosis. This updated summary of guidelines has been developed by experts of the Taiwan Osteoporosis Association with the intention of reducing the risks of osteoporotic fractures and improving the quality of care for patients with osteoporosis. The updated guidelines compile the latest evidence to provide clinicians and other healthcare professionals with practical recommendations for the prevention, diagnosis, and management of osteoporosis under clinical settings in Taiwan.

Original languageEnglish
Pages (from-to)S4-S13
JournalJournal of the Formosan Medical Association
Volume122 Suppl 1
DOIs
StatePublished - 01 2023

Bibliographical note

Copyright © 2023. Published by Elsevier B.V.

Keywords

  • Anti-osteoporosis treatment
  • Fracture liaison service
  • Guidelines
  • Osteoporosis
  • Osteoporotic fracture
  • Osteoporosis/complications
  • Osteoporotic Fractures/prevention & control
  • Humans
  • Quality of Life
  • Secondary Prevention
  • Bone Density Conservation Agents/therapeutic use
  • Taiwan/epidemiology

Fingerprint

Dive into the research topics of 'Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update'. Together they form a unique fingerprint.

Cite this